{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"102"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"1"}]}],"title":"No Cancer treatment at enrollment"},{"categories":[{"measurements":[{"groupId":"OG000","value":"131"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"0"}]}],"title":"Cancer Treatment at enrollment (Chemotherapy)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"0"}]}],"title":"Cancer Treatment at enrollment (Non-chemotherapy)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"158"}]}],"title":"Unknown"}],"denoms":[{"counts":[{"groupId":"OG000","value":"268"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"159"}],"units":"Participants"}],"description":"The distribution of participant cancer treatment at enrollment will be summarized.","groups":[{"description":"Considering or currently receiving cancer treatment\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.\n\nNon-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.","id":"OG000","title":"New, Primary or Recurrent Disease"},{"description":"This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies.\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.\n\nNon-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.","id":"OG001","title":"Metastic or Locally Advanced Cancer"},{"description":"Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy.\n\nNon-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.","id":"OG002","title":"Prior Cancer"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Participants who enrolled in this study","reportingStatus":"POSTED","timeFrame":"Baseline","title":"Describe the Treatment Characteristics of Cancer Patients With HIV Receiving Care at Domestic AMC Sites.","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"Participants"}